TREATMENT OF TYPE-III HYPERLIPOPROTEINEMIA WITH GEMFIBROZIL TO RETARD PROGRESSION OF CORONARY-ARTERY DISEASE

被引:22
作者
KUO, PT [1 ]
WILSON, AC [1 ]
KOSTIS, JB [1 ]
MOREYRA, AB [1 ]
DODGE, HT [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MED,DIV CARDIOVASC DIS,NEW BRUNSWICK,NJ 08903
关键词
D O I
10.1016/0002-8703(88)90253-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:85 / 90
页数:6
相关论文
共 33 条
[1]  
BILHEIMER DW, 1971, CIRCULATION, V44, P56
[2]   TYPE-III HYPERLIPOPROTEINEMIA - DIAGNOSIS, MOLECULAR DEFECTS, PATHOLOGY, AND TREATMENT [J].
BREWER, HB ;
ZECH, LA ;
GREGG, RE ;
SCHWARTZ, D ;
SCHAEFER, EJ .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) :623-640
[3]   ARTERIOGRAPHIC ASSESSMENT OF CORONARY ATHEROSCLEROSIS - REVIEW OF CURRENT METHODS, THEIR LIMITATIONS, AND CLINICAL-APPLICATIONS [J].
BROWN, BG ;
BOLSON, EL ;
DODGE, HT .
ARTERIOSCLEROSIS, 1982, 2 (01) :2-15
[4]  
BROWN MS, 1983, METABOLIC BASIS INHE, P655
[5]  
CABIN HS, 1981, AM HEART J, V102, P831
[6]   PRELIMINARY-REPORT - TREATMENT OF TYPE-3 HYPERLIPOPROTEINEMIA WITH MEVINOLIN [J].
EAST, CA ;
GRUNDY, SM ;
BILHEIMER, DW .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (02) :97-98
[7]   TYPE-III HYPERLIPOPROTEINEMIA - ANALYSIS OF 2 CONTEMPORARY DEFINITIONS [J].
FREDRICKSON, DS ;
MORGANROTH, J ;
LEVY, RI .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) :150-157
[8]   HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE [J].
FRICK, MH ;
ELO, O ;
HAAPA, K ;
HEINONEN, OP ;
HEINSALMI, P ;
HELO, P ;
HUTTUNEN, JK ;
KAITANIEMI, P ;
KOSKINEN, P ;
MANNINEN, V ;
MAENPAA, H ;
MALKONEN, M ;
MANTTARI, M ;
NOROLA, S ;
PASTERNACK, A ;
PIKKARAINEN, J ;
ROMO, M ;
SJOBLOM, T ;
NIKKILA, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) :1237-1245
[9]  
GABELLI C, 1986, J LIPID RES, V27, P326
[10]  
GHISELLI G, 1982, LANCET, V2, P405